产品详情
Targets
Target | Value |
---|---|
VEGFR2 | IC50: 1nM |
RET | IC50: 13nM |
c-Kit | IC50: 429nM |
c-Src | IC50: 530nM |
PDGFRα | IC50: >1μM |
EGFR | IC50: >10μM |
HER2 | IC50: >10μM |
FGFR1 | IC50: >10μM |
In vitro | DMSO | 77 mg/mL (193.72 mM) | |
Water | Insoluble | ||
Ethanol | 10 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.26 mL | 101.3 mL | 202.59 mL |
0.5 mM | 4.05 mL | 20.26 mL | 40.52 mL |
1 mM | 2.03 mL | 10.13 mL | 20.26 mL |
5 mM | 0.41 mL | 2.03 mL | 4.05 mL |
*The above data is based on the productmolecular weight 493.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11407 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 493.6 |
Formula | C25H27N5O4S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 811803-05-1 |
SMILES | CS(=O)(=O)O.C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4 |
产品标签
Product Questions
Product Questions
Buflomedil HCl
Buflomedil HCl是一种用于治疗外周血管疾病的血管活性剂。
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂,可选择性靶向VEGF受体,血小板衍生的生长因子受体(PDGFRs)和Kit受体…
Tivozanib (AV-951)
Tivozanib (AV-951)是一种口服VEGF受体酪氨酸激酶抑制剂,旨在抑制所有三种VEGF受体。
Motesanib Diphosphate (AMG-706)
Motesanib也称为AMG-706,是一种有效的ATP竞争性的VEGFR1/2/3抑制剂,IC50分别为2 nM/3 nM/6 nM;对Kit具有相似的抑制…